| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
78,009 | 78,009 | 74,349 | 72,524 | 69,026 |
| Cost of Revenue
|
-64,695 | -64,695 | -56,823 | -59,915 | -58,410 |
|
Gross Profit
|
13,314 | 13,314 | 17,526 | 12,609 | 10,616 |
| Selling, General and Administrative Expenses
|
-12,656 | -12,656 | -15,112 | -12,446 | -9,880 |
| Depreciation, Amortization and Depletion
|
-2,644 | -2,644 | -3,071 | -2,945 | -2,703 |
| Other Income/Expense, Operating
|
57 | 57 | -27 | 211 | 271 |
|
Operating Income/Expenses
|
-15,243 | -15,243 | -18,210 | -15,180 | -12,312 |
|
Total Operating Profit/Loss
|
-1,929 | -1,929 | -684 | -2,571 | -1,696 |
| Total Net Finance Income/Expense
|
-672 | -672 | -789 | -1,145 | -723 |
| Irregular Income/Expenses
|
0 | 0 | -291 | 0 | -138 |
|
Non-Operating Income/Expenses, Total
|
-672 | -672 | -1,080 | -1,145 | -861 |
|
Pretax Income
|
-2,601 | -2,601 | -1,764 | -3,716 | -2,557 |
|
Provision for Income Tax
|
-366 | -366 | -456 | 493 | 10 |
|
Net Income from Continuing Operations
|
-2,967 | -2,967 | -2,220 | -3,223 | -2,547 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-2,967 | -2,967 | -2,220 | -3,223 | -2,547 |
|
Non-Controlling/Minority Interests
|
530 | 530 | 278 | -16 | 15 |
|
Net Income after Non-Controlling/Minority Interests
|
-2,437 | -2,437 | -1,942 | -3,239 | -2,532 |
|
Net Income Available to Common Stockholders
|
-2,437 | -2,437 | -1,942 | -3,239 | -2,532 |
|
Diluted Net Income Available to Common Stockholders
|
-2,437 | -2,437 | -1,942 | -3,239 | -2,532 |
| Basic EPS
|
-0.06 | -0.06 | -0.05 | -0.10 | -0.07 |
| Diluted EPS
|
-0.06 | -0.06 | -0.05 | -0.10 | -0.07 |
|
Basic Weighted Average Shares Outstanding
|
38,417.9870 | 38,417.9870 | 37,584 | 33,929 | 35,550 |
|
Diluted Weighted Average Shares Outstanding
|
38,417.9870 | 38,417.9870 | 37,584 | 33,929 | 35,550 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,929 | -1,929 | -975 | -2,571 | -1,834 |
|
EBITDA
|
1,591 | 1,591 | 3,006 | 1,301 | 1,822 |
|
Normalized EBITDA
|
1,728 | 1,728 | 5,066 | 1,288 | 1,774 |
|
Normalized Income
|
-2,853.2900 | -2,853.2900 | -460.7300 | -3,234.2753 | -2,594.2726 |
|
Total Unusual Items
|
137 | 137 | 2,060 | -13 | -48 |
|
Total Unusual Items Excluding Goodwill
|
137 | 137 | 1,769 | -13 | -186 |
3/31/2023 - 10/9/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade